Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer

To date, few studies have reported the prognostic value of pre-treatment hemoglobin levels in patients with non-small cell lung cancer (NSCLC). In the present study, 416 patients with NSCLC were retrospectively reviewed. Univariate Cox proportional hazards regression analysis demonstrated that patie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Clin Oncol
Hlavní autoři: Zhang, Yue-Hua, Lu, Yuquan, Lu, Hong, Zhang, Meng-Wei, Zhou, Yue-Min, Li, Xiang-Lei, Lv, Pin, Zhao, Xiao-Yan
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2018
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995083/
https://ncbi.nlm.nih.gov/pubmed/29896399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1628
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky